×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: EU | MED | Malaria | Vaccine

EU Drug Regulator Recommends 1st License for Malaria Shot

Friday, 24 July 2015 05:56 AM

LONDON (AP) — The European Medicines Agency is recommending that the world's leading malaria vaccine be licensed even though it is only about 30 percent effective and that protection fades over time.

In a statement published on Friday, the agency said it had "adopted a positive scientific opinion" for the vaccine's use outside the European Union, a regulatory process that helps speed new medicines to the market.

The vaccine, known as Mosquirix, protects only about one-third of children though it might help protect some kids from getting the parasitic disease. There are about 200 million cases of malaria every year, mostly in African children.

Drug maker GlaxoSmithKline has spent hundreds of millions of dollars on the vaccine, which is intended for use in areas with high malaria rates.

© Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


Europe
The European Medicines Agency is recommending that the world's leading malaria vaccine be licensed even though it is only about 30 percent effective and that protection fades over time.In a statement published on Friday, the agency said it had "adopted a...
EU,MED,Malaria,Vaccine
127
2015-56-24
Friday, 24 July 2015 05:56 AM
Newsmax Media, Inc.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
 
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved